SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-131273
Filing Date
2021-10-28
Accepted
2021-10-28 20:54:17
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2131250-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2131250-4_3seq1.xml 3 1589
2 EXHIBIT 24 tm2131250d4_ex24.htm EX-24 8297
  Complete submission text file 0001104659-21-131273.txt   11330
Mailing Address C/O AVEXIS, INC., 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address
Nuechterlein Carole (Reporting) CIK: 0001665133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40969 | Film No.: 211360201

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations